Diversified Trust CO Puma Biotechnology, Inc. Transaction History

Diversified Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$1.64 - $3.3 $8,956 - $18,021	-5,461 Reduced 21.3%	20,175 $57,000
Q1 2022 Apr 07, 2022	SELL	$2.13 - $3.24 $110 - $168	-52 Reduced 0.2%	25,636 $74,000
Q4 2021 Jan 13, 2022	BUY	$2.85 - $6.58 $17,251 - $39,828	6,053 Added 30.83%	25,688 $78,000
Q3 2021 Jan 13, 2022	SELL	$6.63 - $9.39 $47,968 - $67,936	-7,235 Reduced 26.93%	19,635 $138,000
Q2 2021 Jul 20, 2021	BUY	$8.98 - $11.6 $136,657 - $176,528	15,218 Added 130.6%	26,870 $247,000
Q1 2021 May 10, 2021	SELL	$9.38 - $13.63 $19,369 - $28,145	-2,065 Reduced 15.05%	11,652 $113,000
Q4 2020 Jan 08, 2021	BUY	$7.78 - $12.13 $106,718 - $166,387	13,717 New	13,717 $141,000

110

28.3M

27.9K

3.4K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $155M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.